Search

Sartorius Stedim Biotech.

Uždarymo kaina

SektoriusFinansų sektorius

178.2 2.53

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

173.1

Max

180.3

Pagrindiniai rodikliai

By Trading Economics

Pajamos

4.9M

93M

Pardavimai

4.2M

766M

P/E

Sektoriaus vid.

56.921

19.1

Pelnas, tenkantis vienai akcijai

1.25

Dividendų pajamingumas

0.41

Pelno marža

12.146

Darbuotojai

10,477

EBITDA

9.2M

240M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+31.96% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.41%

4.56%

Kitas uždarbis

2026-10-22

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-808M

17B

Ankstesnė atidarymo kaina

175.67

Ankstesnė uždarymo kaina

178.2

Naujienos nuotaikos

By Acuity

13%

87%

21 / 438 reitingas Finance

Sartorius Stedim Biotech. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-06 23:56; UTC

News

Clear Secure Inc launched a Corporate Memberships program to improve business travel, combining services like CLEAR+ and TSA PreCheck. Shares are trading higher after the announcement.

2026-08-06 23:56; UTC

News

Shares declined after-hours despite JP Morgan raising price target to $545.

2026-08-06 23:52; UTC

News

First Solar supports Section 232 action on polysilicon imports, benefiting U.S. manufacturing. Shares have moved sharply higher in after-market trading.

2026-08-06 23:51; UTC

News

The Invesco Currencyshares Japanese Yen Trust is lower in after-market hours, reflecting broader market movements amid ongoing U.S. and Japan currency interventions.

2026-08-06 23:51; UTC

News

LeMaitre Vascular Inc shares declined in after-market trading, nearing the lower end of their one-month range amid broader market volatility from Middle East supply concerns.

2026-08-06 23:51; UTC

News

Maravai LifeSciences reported second-quarter revenue of $51.4 million, exceeding expectations, but shares are lower in after-market trading amid a cautious full-year outlook.

2026-08-06 23:51; UTC

News

Fox Factory Holding Corp reported Q2 sales of $358.1 million, exceeding expectations. The company raised its full-year guidance, and shares advanced in after-market trading.

2026-08-06 23:51; UTC

News
Social Media

Twilio Inc reported second-quarter revenue of $1.50 billion, exceeding estimates. Shares are trading sharply higher in after-market hours following the strong results.

2026-08-06 23:51; UTC

News
Social Media

Indie Semiconductor reports second-quarter revenue of $64 million, exceeding estimates. Shares are trading higher in after-market hours on positive guidance for Q3.

2026-08-06 23:51; UTC

News
Social Media

Halozyme Therapeutics shares advanced in after-market trading following record second-quarter results, with revenue rising to $481 million and guidance increased for the year.

2026-08-06 23:51; UTC

News
Social Media

Onto Innovation shares rose in after-market trading following record revenue of $343 million and adjusted EPS of $1.93, both exceeding analyst expectations.

2026-08-06 23:51; UTC

News
Social Media

Airbnb Inc. reported second-quarter revenue of $3.61 billion, exceeding estimates. Shares rose significantly in after-market trading, despite earlier pulling back from a session high.

2026-08-06 23:46; UTC

News
Social Media

Republic Services reported strong second-quarter earnings and raised full-year adjusted EPS guidance. The stock was trading roughly flat in after-market hours.

2026-08-06 23:46; UTC

News

McDonald's shares are lower in after-market trading as CEO Chris Kempczinski discusses challenges with the company's value menu strategy and execution issues.

2026-08-06 23:42; UTC

Social Media
News

DraftKings shares are lower in after-market hours following a net loss of $67.6 million and revenue that fell short of estimates.

2026-08-06 23:41; UTC

News
Social Media

MP Materials reported second-quarter revenue of $108.5 million, exceeding expectations. Shares are trading higher in after-market hours following the earnings announcement.

2026-08-06 23:41; UTC

News
Social Media

Doximity reported fiscal Q1 revenue of $156.6 million, exceeding expectations. The company raised its FY2027 revenue guidance, driving shares higher in after-hours trading.

2026-08-06 23:41; UTC

News

nLIGHT Inc shares are sharply lower in after-market trading following mixed Q2 results and cautious guidance, projecting revenues below analyst expectations.

2026-08-06 23:41; UTC

Social Media
Event
News

Dropbox Inc. shares declined in after-market trading despite reporting Q2 revenue of $631.5 million, exceeding expectations. Concerns over stagnant growth contributed to the drop.

2026-08-06 23:36; UTC

News

First Business Financial Services Inc shares are higher in after-market hours, positioned near the upper end of their one-month trading range.

2026-08-06 23:36; UTC

News

Navient Corp reported second quarter earnings of $0.26 per share, exceeding expectations, but shares are trading lower in after-market hours amid revenue decline.

2026-08-06 23:36; UTC

News

Canaccord Genuity maintained its Hold rating on Zillow Group and lowered its price target to $40. Shares are trading roughly flat after market hours.

2026-08-06 23:32; UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

2026-08-06 23:31; UTC

News

Arlo Technologies reported second-quarter revenue of $156 million and raised fiscal year 2026 guidance, contributing to a notable increase in after-market trading.

2026-08-06 23:31; UTC

News
Social Media

Akamai Technologies reported second-quarter revenue of $1.1 billion and adjusted EPS of $1.59, both exceeding analyst expectations. The stock is higher in after-market trading.

2026-08-06 23:31; UTC

News
Social Media

Figs Inc. reported second-quarter revenues of $196.6 million and raised its full-year growth forecast, contributing to a notable rise in after-market trading.

2026-08-06 23:31; UTC

News
Social Media

Ardelyx Inc. reports Q2 revenue of $118.1 million, missing expectations. Shares decline in after-market trading following revised financial guidance and a net loss of $16.7 million.

2026-08-06 23:31; UTC

News

Regenxbio Inc shares are higher in after-market hours following key milestones in its Q2 2026 earnings call, including FDA alignment for RGX-202's development.

2026-08-06 23:31; UTC

News
Social Media

Sweetgreen Inc. shares fell sharply in after-market trading following a significant net loss and revenue miss in its second-quarter results.

2026-08-06 23:31; UTC

News
Social Media

Trade Desk Inc shares declined sharply after reporting second-quarter revenue of $715 million, missing expectations, and providing weak guidance for the third quarter.

Akcijų palyginimas

Kainos pokytis

Sartorius Stedim Biotech. Prognozė

Kainos tikslas

By TipRanks

31.96% į viršų

12 mėnesių prognozė

Vidutinis 230 EUR  31.96%

Aukščiausias 260 EUR

Žemiausias 210 EUR

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Sartorius Stedim Biotech. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

5 ratings

4

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

21 / 438 reitingas Finansų sektorius

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat